Clinitech Laboratory Ltd — Others, 07-04-2025: Disclosure under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025.

Clinitech Laboratory Limited has disclosed that, for the quarter ended March 31, 2025, the entire holding of its shares is in dematerialized form, with no requests for re-materialization received. This confirms compliance with SEBI regulations, underscoring the company's operational clarity and shareholder management. The absence of rematerialization requests suggests strong investor confidence in holding shares electronically. This update may positively influence investor sentiment, as it reflects stability and a streamlined operational approach in managing shareholding processes.